With sales of potential blockbuster Lokelma scaling up, AstraZeneca is bolstering its production of the hyperkalemia treatment with a $445 million injection of funds. The investment will increase the capabilities of AZ’s manufacturing facility in Coppell, Texas, which is the company’s lone site in the world that produces Lokelma.
AstraZeneca to spend $445M to boost production of Lokelma at Texas plant
Latest from Blog
Lawmakers discuss how to fund school safety and nutrition
CHEYENNE – Against the backdrop of a legal funding battle over the future of Wyoming’s education system, state lawmakers gathered in Lander this week to discuss the ongoing work of Post Views:
Webinar preview: Rousselot backs whey-collagen peptide blends for cost and nutrition
Due to the popularity of high-protein food and nutrition, the price of whey ingredients has gone up substantially in recent years, cautions Rousselot. Driven by these market restraints and an increasing awareness
How Sea Moss Became a Must-Have Supplement in the Wellness Community
True Sea Moss describes sea moss as a ‘superfood.’ Superfoods have been a major draw for many consumers searching for natural ways to supplement their diets. Post Views: 0
Champion Petfoods Unveils $32M CAD Global Innovation and Discovery Centre, Bringing Advanced Science and Nutritional Excellence to its Pioneering Legacy in Crafting ‘The World’s Best Pet Food’
The $32 million CAD state-of-the-art Innovation and Discovery Centre reinforces Champion’s long-term commitment to its Canadian operations, with an additional investment of $15 million CAD planned over the next five Post Views: